Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - carbidopa monohydrate, quantity: 26.9 mg; levodopa, quantity: 100 mg - tablet, uncoated - excipient ingredients: povidone; purified talc; sodium starch glycollate; microcrystalline cellulose; quinoline yellow aluminium lake; maize starch; magnesium stearate - treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. levodopa/carbidopa is frequently helpful in the management of tremor, dysphagia, sialorrhoea, and postural instability associated with parkinson's disease and syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - carbidopa monohydrate 26.9mg equivalent to carbidopa 25 mg (contains approx. 7% moisture); levodopa 100mg - tablet - 100mg/25mg - active: carbidopa monohydrate 26.9mg equivalent to carbidopa 25 mg (contains approx. 7% moisture) levodopa 100mg excipient: magnesium stearate microcrystalline cellulose povidone purified talc quinoline yellow sodium starch glycolate starch - kinson is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. kinson frequently is helpful in the management of tremor, dysphagia, sialorrhea, and postural instability associated with parkinson's disease and syndrome. when therapeutic response to levodopa alone is irregular, and signs and symptoms of parkinson's disease are not evenly controlled throughout the day, substitution of kinson usually is effective in reducing fluctuations in response. by reducing certain adverse reactions produced by levodopa alone, kinson permits more patients to obtain adequate relief of the symptoms of parkinson's disease. kinson is also indicated for patients with parkinsonism who are taking vitamin preparations that contain pyridoxine hydrochloride (vitamin b6).

Canada - English - Health Canada

apotex inc - carbidopa; levodopa - tablet - 10mg; 100mg - carbidopa 10mg; levodopa 100mg - dopamine precursors

Canada - English - Health Canada

pro doc limitee - carbidopa; levodopa - tablet - 25mg; 100mg - carbidopa 25mg; levodopa 100mg - dopamine precursors

Ireland - English - HPRA (Health Products Regulatory Authority)

clear pharmacy - levodopa, carbidopa - tablets - 25/100 milligram - dopa and dopa derivatives

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - carbidopa levodopa - tablets - 25/250 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - carbidopa levodopa - tablets - 10/100 milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - carbidopa monohydrate 27mg equivalent to carbidopa 25 mg; levodopa 100mg - modified release tablet - 25/100 - active: carbidopa monohydrate 27mg equivalent to carbidopa 25 mg levodopa 100mg excipient: ethanol hyprolose iron oxide red magnesium stearate polyvinyl acetate purified water

Philippines - English - FDA (Food And Drug Administration)

merck sharp & dohme (i.a.) llc - levodopa , carbidopa (as monohydrate) - tablet - 100mg/25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - carbidopa monohydrate; levodopa - oral tablet - 12.5mg ; 50mg